LAVA Therapeutics N.V. (LVTX) Misses Q2 EPS by 2c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q2 EPS of ($0.32), $0.02 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• Visa deposits $405M into U.S. litigation escrow, adjusting stock rates
• Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance